Litcius/Paper detail

Dihydrotanshinone I attenuates estrogen-deficiency bone loss through RANKL-stimulated NF-κB, ERK and NFATc1 signaling pathways

Chao Ma, Liang Mo, Zhangzheng Wang, Deqiang Peng, Chi Zhou, Wei Niu, Yuhao Liu, Zhenqiu Chen

2023International Immunopharmacology16 citationsDOI

Topics & Concepts

OsteoclastSalvia miltiorrhizaMAPK/ERK pathwayRANKLOsteoporosisOvariectomized ratEstrogenSignal transductionPharmacologyChemistryNF-κBInhibitory postsynaptic potentialMedicineCancer researchInternal medicineEndocrinologyTraditional Chinese medicineActivator (genetics)ReceptorBiochemistryPathologyAlternative medicineBone Metabolism and DiseasesBone health and treatmentsNF-κB Signaling Pathways
Dihydrotanshinone I attenuates estrogen-deficiency bone loss through RANKL-stimulated NF-κB, ERK and NFATc1 signaling pathways | Litcius